Altamira Therapeutics Ltd Stock Ownership - Who owns Altamira Therapeutics?

Insider buying vs selling

Have Altamira Therapeutics Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CYTO insiders and whales buy or sell their stock.

CYTO Shareholders

What type of owners hold Altamira Therapeutics Ltd stock?
Citigroup Inc0.04%3,074$2.52kInstitution
Ubs Group Ag0.02%1,532$1.25kInstitution
Morgan Stanley0.01%1,025$839.48Institution
Wells Fargo Company0.00%25$20.48Institution
Advisor Group Holdings Inc0.00%15$12.29Institution
Cutler Group LLC0.00%10$8.19Institution
Stonebridge Capital Advisors LLC0.00%5$4.10Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

CYTO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OGEN0.14%99.86%Net Selling
PHIO0.04%99.96%Net BuyingNet Selling
SNPX3.58%3.66%Net Selling

Altamira Therapeutics Stock Ownership FAQ

Who owns Altamira Therapeutics?

Altamira Therapeutics (NASDAQ: CYTO) is owned by 0.08% institutional shareholders, 0.00% Altamira Therapeutics insiders, and 99.92% retail investors. Citigroup Inc is the largest individual Altamira Therapeutics shareholder, owning 3074.00 shares representing 0.04% of the company. Citigroup Inc's Altamira Therapeutics shares are currently valued at $2.70k.

If you're new to stock investing, here's how to buy Altamira Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.